Cargando…

Virtual Dual inhibition of COX-2 / 5-LOX enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug

Hydro-alcoholic fruit extract of Cordia myxa was considerably effective on curing acute inflammation in mouse model. Previous studies suggested significant anti-inflammatory activities as well as potential anticancer agent of α-amyrins in seeds. Inhibition of Cyclooxygenase-2 (COX-2) and 5-Lipooxyge...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjbar, Mohammad Mehdi, Assadolahi, Vahideh, Yazdani, Mohsen, Nikaein, Donya, Rashidieh, Behnam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874318/
https://www.ncbi.nlm.nih.gov/pubmed/27231478
http://dx.doi.org/10.17179/excli2016-164
_version_ 1782433035531059200
author Ranjbar, Mohammad Mehdi
Assadolahi, Vahideh
Yazdani, Mohsen
Nikaein, Donya
Rashidieh, Behnam
author_facet Ranjbar, Mohammad Mehdi
Assadolahi, Vahideh
Yazdani, Mohsen
Nikaein, Donya
Rashidieh, Behnam
author_sort Ranjbar, Mohammad Mehdi
collection PubMed
description Hydro-alcoholic fruit extract of Cordia myxa was considerably effective on curing acute inflammation in mouse model. Previous studies suggested significant anti-inflammatory activities as well as potential anticancer agent of α-amyrins in seeds. Inhibition of Cyclooxygenase-2 (COX-2) and 5-Lipooxygenase (5-LOX) is significant in cancer prevention and therapeutics although this inhibition with chemo-drugs has its own side-effects. It is shown that these enzymes pathways are related to several cancers including colon, breast and lung cancer. This study was conducted based on Cordia species' α-amyrins as a safer natural anti-cancer compound for inhibition of COX-2 and 5-LOX enzymes by molecular docking. The X-ray crystal structure of COX2 / 5-LOX enzymes and α-amyrins was retrieved and energetically minimized respectively. The binding site and surface of enzymes were detected. Docking studies were performed by AutoDock 4.2 using Lamarckian genetic algorithm (LGA). Finally drug likeness, molecular pharmacokinetic properties and toxicity of α-amyrins was calculated. Molecular Docking revealed hydrogen and hydrophobic interactions between α-amyrins with both active sites of COX-2 and 5-LOX enzymes. Interestingly, it covalently bonded to Fe cofactor of 5-LOX enzyme and chelated this molecule. Base on binding energies (∆G) α-amyrin has more inhibitory effects on 5-LOX (-10.45 Kcal/mol) than COX-2 (-8.02 Kcal/mol). Analysis of molecular pharmacokinetic parameters suggested that α-amyrins complied with most sets of Lipinski's rules, and so it could be a suitable ligand for docking studies. Eventually, bioactivity score showed α-amyrins possess considerable biological activities as nuclear receptor, enzyme inhibitor, GPCR and protease inhibitor ligand. These results clearly demonstrate that α-amyrins could act as potential highly selective COX-/5-LOX inhibitor. Also, it is a safe compound in comparison with classical non-steroidal anti-inflammatory drugs (NSAIDs) that are known as cancer preventive agents, since it is free of side effects on human body and it can be a promising drug for cancer therapeutics.
format Online
Article
Text
id pubmed-4874318
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Leibniz Research Centre for Working Environment and Human Factors
record_format MEDLINE/PubMed
spelling pubmed-48743182016-05-26 Virtual Dual inhibition of COX-2 / 5-LOX enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug Ranjbar, Mohammad Mehdi Assadolahi, Vahideh Yazdani, Mohsen Nikaein, Donya Rashidieh, Behnam EXCLI J Original Article Hydro-alcoholic fruit extract of Cordia myxa was considerably effective on curing acute inflammation in mouse model. Previous studies suggested significant anti-inflammatory activities as well as potential anticancer agent of α-amyrins in seeds. Inhibition of Cyclooxygenase-2 (COX-2) and 5-Lipooxygenase (5-LOX) is significant in cancer prevention and therapeutics although this inhibition with chemo-drugs has its own side-effects. It is shown that these enzymes pathways are related to several cancers including colon, breast and lung cancer. This study was conducted based on Cordia species' α-amyrins as a safer natural anti-cancer compound for inhibition of COX-2 and 5-LOX enzymes by molecular docking. The X-ray crystal structure of COX2 / 5-LOX enzymes and α-amyrins was retrieved and energetically minimized respectively. The binding site and surface of enzymes were detected. Docking studies were performed by AutoDock 4.2 using Lamarckian genetic algorithm (LGA). Finally drug likeness, molecular pharmacokinetic properties and toxicity of α-amyrins was calculated. Molecular Docking revealed hydrogen and hydrophobic interactions between α-amyrins with both active sites of COX-2 and 5-LOX enzymes. Interestingly, it covalently bonded to Fe cofactor of 5-LOX enzyme and chelated this molecule. Base on binding energies (∆G) α-amyrin has more inhibitory effects on 5-LOX (-10.45 Kcal/mol) than COX-2 (-8.02 Kcal/mol). Analysis of molecular pharmacokinetic parameters suggested that α-amyrins complied with most sets of Lipinski's rules, and so it could be a suitable ligand for docking studies. Eventually, bioactivity score showed α-amyrins possess considerable biological activities as nuclear receptor, enzyme inhibitor, GPCR and protease inhibitor ligand. These results clearly demonstrate that α-amyrins could act as potential highly selective COX-/5-LOX inhibitor. Also, it is a safe compound in comparison with classical non-steroidal anti-inflammatory drugs (NSAIDs) that are known as cancer preventive agents, since it is free of side effects on human body and it can be a promising drug for cancer therapeutics. Leibniz Research Centre for Working Environment and Human Factors 2016-03-23 /pmc/articles/PMC4874318/ /pubmed/27231478 http://dx.doi.org/10.17179/excli2016-164 Text en Copyright © 2016 Ranjbar et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited.
spellingShingle Original Article
Ranjbar, Mohammad Mehdi
Assadolahi, Vahideh
Yazdani, Mohsen
Nikaein, Donya
Rashidieh, Behnam
Virtual Dual inhibition of COX-2 / 5-LOX enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug
title Virtual Dual inhibition of COX-2 / 5-LOX enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug
title_full Virtual Dual inhibition of COX-2 / 5-LOX enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug
title_fullStr Virtual Dual inhibition of COX-2 / 5-LOX enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug
title_full_unstemmed Virtual Dual inhibition of COX-2 / 5-LOX enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug
title_short Virtual Dual inhibition of COX-2 / 5-LOX enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug
title_sort virtual dual inhibition of cox-2 / 5-lox enzymes based on binding properties of alpha-amyrins, the anti-inflammatory compound as a promising anti-cancer drug
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874318/
https://www.ncbi.nlm.nih.gov/pubmed/27231478
http://dx.doi.org/10.17179/excli2016-164
work_keys_str_mv AT ranjbarmohammadmehdi virtualdualinhibitionofcox25loxenzymesbasedonbindingpropertiesofalphaamyrinstheantiinflammatorycompoundasapromisinganticancerdrug
AT assadolahivahideh virtualdualinhibitionofcox25loxenzymesbasedonbindingpropertiesofalphaamyrinstheantiinflammatorycompoundasapromisinganticancerdrug
AT yazdanimohsen virtualdualinhibitionofcox25loxenzymesbasedonbindingpropertiesofalphaamyrinstheantiinflammatorycompoundasapromisinganticancerdrug
AT nikaeindonya virtualdualinhibitionofcox25loxenzymesbasedonbindingpropertiesofalphaamyrinstheantiinflammatorycompoundasapromisinganticancerdrug
AT rashidiehbehnam virtualdualinhibitionofcox25loxenzymesbasedonbindingpropertiesofalphaamyrinstheantiinflammatorycompoundasapromisinganticancerdrug